Cumberland Pharmaceuticals CPIX Other revenue — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's other revenue — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's other revenue — revenue?
- Cumberland Pharmaceuticals (CPIX) reported other revenue — revenue of $168.85K in Q1 2026.
- How has Cumberland Pharmaceuticals's other revenue — revenue changed year-over-year?
- Cumberland Pharmaceuticals's other revenue — revenue decreased by 94.6% year-over-year, from $3.14M to $168.85K.
- What does other revenue — revenue mean?
- This metric represents the gross revenue generated from secondary product lines or ancillary services that fall outside the company's primary therapeutic focus areas. It captures the total inflow of economic benefits from these non-core offerings before accounting for any sales returns, allowances, or discounts. Monitoring this figure helps investors assess the contribution of diversified product streams to the company's overall top-line performance.